Advertisement
Advertisement
PRE
Prenetics Global Limited Class A Ordinary Share
17.57
USDSponsored
-0.42
-2.33%
May 13, 15:59 UTC -4
Closed
After-Market
17.77
+0.20
+1.14%
PRE Earnings Reports
Positive Surprise Ratio
PRE beat 6 of 13 last estimates.
46%
Next Report
Today BMO
Date of Next Report
May 14, 2026
Estimate for Q1 26 (Revenue/ EPS)
$38.23M
/-$0.94
Implied change from Q4 25 (Revenue/ EPS)
+4.57%
/-46.29%
Implied change from Q1 25 (Revenue/ EPS)
+120.82%
/+17.50%
Prenetics Global Limited Class A Ordinary Share earnings per share and revenue
On Feb 18, 2026, PRE reported earnings of -1.75 USD per share (EPS) for Q4 25, missing the estimate of -0.34 USD, resulting in a -404.61% surprise. Revenue reached 36.56 million, compared to an expected 33.77 million, with a 8.26% difference. The market reacted with a -7.73% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 2 analysts forecast an EPS of -0.94 USD, with revenue projected to reach 38.23 million USD, implying an decrease of -46.29% EPS, and increase of 4.57% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Kamada Ltd
Report Date
May 13, 2026 For Q1 26
Estimate
$0.11
Actual
$0.07
Surprise
-40.32%
Abeona Therapeutics Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.36
Actual
-$0.30
Surprise
+17.31%
Milestone Pharmaceuticals Inc. Common Shares
Report Date
May 13, 2026 For Q1 26
Estimate
$0.31
Actual
-$0.20
Surprise
-163.94%
Spero Therapeutics, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.18
Actual
-$0.13
Surprise
+29.19%
Equillium, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.04
Actual
-$0.06
Surprise
-34.53%
Spruce Biosciences, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$8.99
Actual
-$8.94
Surprise
+0.58%
BeyondSpring Inc. Ordinary Shares
Report Date
May 13, 2026 For Q1 26
Estimate
-Actual
-$0.05
Surprise
-
Tango Therapeutics, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.31
Actual
-$0.32
Surprise
-0.13%
Longeveron Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.16
Actual
-$0.19
Surprise
-12.89%
Bionano Genomics, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.96
Actual
-$0.76
Surprise
+21.57%
FAQ
What were Prenetics Global Limited Class A Ordinary Share's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Prenetics Global Limited Class A Ordinary Share reported EPS of -$1.75, missing estimates by -404.61%, and revenue of $36.56M, 8.26% above expectations.
How did the market react to Prenetics Global Limited Class A Ordinary Share's Q4 2025 earnings?
The stock price moved down -7.73%, changed from $21.74 before the earnings release to $20.06 the day after.
When is Prenetics Global Limited Class A Ordinary Share expected to report next?
The next earning report is scheduled for May 14, 2026.
What are the forecasts for Prenetics Global Limited Class A Ordinary Share's next earnings report?
Based on 2
analysts, Prenetics Global Limited Class A Ordinary Share is expected to report EPS of -$0.94 and revenue of $38.23M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement